According to Veru's latest financial reports the company's current earnings (TTM) are -$75.31 M. an increase over its 2022 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$75.31 M | -32.75% |
2022 | -$0.12 B | 673.72% |
2021 | -$14.48 M | -375.47% |
2020 | $5.25 M | -157.74% |
2019 | -$9.1 M | -32.09% |
2018 | -$13.4 M | 1.17% |
2017 | -$13.25 M | -1349.01% |
2016 | $1.06 M | -85.97% |
2015 | $7.55 M | 99.18% |
2014 | $3.79 M | -51.18% |
2013 | $7.77 M | -33.9% |
2012 | $11.75 M | 108.3% |
2011 | $5.64 M | 3.75% |
2010 | $5.44 M | -20.61% |
2009 | $6.85 M | 136.88% |
2008 | $2.89 M | |
2006 | -$0.08 M | 26.36% |
2005 | -$0.07 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 144.77% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -74.84% | ๐บ๐ธ USA |